| Rivopharm SA - Nortriptyline Rivopharm 25 mg, compresse rivestite con film | | 69554 | | 02 | | Nortriptyline Rivopharm 25 mg | | compresse rivestite con film | | N06AA10 | | Nortriptylin | | 27.02.2025 | | |
| | Composition | | nortriptylinum 25 mg ut nortriptylini hydrochloridum, lactosum monohydricum 107.4 mg, calcii hydrogenophosphas, amylum pregelificatum, magnesii stearas, coperta: hypromellosum, macrogolum 8000, macrogolum 400, E 110 0.04 mg, pro compresso obducto. | | Packungsbestandteile | | compresse rivestite con film | | | | Principe actif | Concentr. |
|---|
| Nortriptyline | 25 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Amylum Pregelificatum | | | | Calcium Hydrogenophosphate | | | | E 110 | 0.04 mg | color. | | Hypromellosum | | coperta | | Lactose Monohydrate | 107.4 mg | | | Macrogol | 400 | | | Magnesii Stearas | | | | Pro Compresso Obducto | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 50 | DDP | DDP | B | | Non |
|
|
